SIMARD JOHN (Chief Executive Officer) sold 1.2% of their position (51.20K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $753.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/28/2021ACC: 0001209191-21-057877
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-51.20K
Net shares
Net seller
$753.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
51.20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−9.89K
Price / share
$14.68
Trade value
$145.22K
% of position
0.2%
9/23/2021
4.12M→4.11M
Common Stock
Direct
Shares
−11.42K
Price / share
$14.49
Trade value
$165.41K
% of position
0.3%
9/24/2021
4.11M→4.10M
Common Stock
Direct
Shares
−29.89K
Price / share
$14.81
Trade value
$442.79K
% of position
0.7%
9/27/2021
4.10M→4.07M
Total
Net shares
−51.20K
Net value
-$753.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2021 | S · Sale | −9.89K | $14.68 | $145.22K | 0.2% | 4.12M | 4.11M |
| Common Stock Direct | 9/24/2021 | S · Sale | −11.42K | $14.49 | $165.41K | 0.3% | 4.11M | 4.10M |
| Common Stock Direct | 9/27/2021 | S · Sale | −29.89K | $14.81 | $442.79K | 0.7% | 4.10M | 4.07M |
| Total | −51.20K | -$753.42K | ||||||
Derivative Transactions0
No derivative transactions reported